Phan Dillon
Director Técnico/Científico/I+D en IBIO, INC. .
Cargos activos de Phan Dillon
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| IBIO, INC. | Director Técnico/Científico/I+D | - | - |
Historial de carrera de Phan Dillon
Antiguos cargos conocidos de Phan Dillon.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PFENEX INC. | Corporate Officer/Principal | - | - |
Ferring Pharmaceuticals, Inc.
 Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Corporate Officer/Principal | - | - |
Formación de Phan Dillon.
| The University of Texas at Austin | Doctorate Degree |
| University of California, Davis | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
Operativa
| Doctorate Degree | 2 |
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| IBIO, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Health Technology |
Pelican Inc
 Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Phan Dillon
- Experiencia
